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Abstract 
S-acylation is a reversible lipid modification occurring on cysteine residues mediated by a 
family of membrane-bound ³]'++&´ enzymes. S-acylation predominantly results in 
anchoring of soluble proteins to membrane compartments or in the trafficking of membrane 
proteins to different compartments. Recent work has shown that although S-acylation of 
some proteins may involve very weak interactions with zDHHC enzymes, a pool of zDHHC 
enzymes exhibit strong and specific interactions with substrates, thereby recruiting them for 
S-acylation. For example, the ankyrin-repeat domains of zDHHC17 and zDHHC13 interact 
specifically with unstructured consensus sequences present in some proteins, thus 
contributing to substrate specificity of these enzymes. In addition to this new information on 
zDHHC enzyme protein substrate specificity, recent work has also identified marked 
differences in selectivity of zDHHC enzymes for acyl CoA substrates and has started to 
unravel the underlying molecular basis for this lipid selectivity. This review will focus on the 
protein and acyl CoA selectivity of zDHHC enzymes. 
 
Lipidation of intracellular proteins 
Intracellular proteins are subject to an array of different chemical modifications. Several of 
these modifications involve the attachment of lipid groups either during protein translation or 
following protein synthesis; lipid modifications found on intracellular proteins include N-
myristoylation, isoprenylation and S-acylation [1]. N-myristoylation is predominantly a co-
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translational modification, whereby myristate is added to a glycine at position 2 of the 
polypeptide chain following cleavage of the initiating methionine. In contrast, isoprenylation 
occurs post-translationally and involves the addition of farnesyl or geranylgeranyl groups 
onto C-terminal cysteines. Both N-myristoylation and isoprenylation are irreversible and are 
catalysed by soluble enzymes that recognise specific consensus sequences, for example, 
MGXXXS/T in the case of N-myristoyltransferases and CAAX or CC in the case of 
isoprenyltransferases. N-myristoylation and isoprenylation typically occur on soluble proteins 
and provide a means for membrane association, since these hydrophobic modifications have 
an affinity for the hydrophobic core of membranes. N-myristoylation and isoprenylation have 
been well-characterised and the enzymes that catalyse these modifications are recognised 
as valid drug targets, for example in cancer and infectious diseases [2, 3]. 
S-acylation involves the attachment of fatty acids onto cysteine residues [4]. This 
modification exhibits a number of important differences from N-myristoylation and 
isoprenylation, including the fact that it is reversible and catalysed by polytopic membrane-
bound enzymes [5, 6]. All classes of protein lipidation reactions have benefitted from recent 
technological breakthroughs, such as the use of high sensitivity click chemistry approaches 
with azide/alkyne fatty acid analogues; previously the study of protein lipidation relied almost 
exclusively on tritiated chemical probes that have a very low sensitivity of detection [7-9]. 
Although it is possible that the alkyne/azide groups present on the acyl probes used for click 
chemistry could exert an influence on the S-acylation reaction or have downstream effects 
on modified proteins, recent work showed that azide probes are excellent mimics of 
endogenous fatty acids and are converted to the expected acyl CoA species upon cell 
labelling [10]. Furthermore, these probes competed with endogenous fatty acids of the same 
chain length for conversion into acyl CoA [10]. Notwithstanding this, it is important that 
further general analysis of these fatty acid analogues are conducted, in particular whether 
the azide/alkyne groups have any influence on protein behaviour. Click chemistry has 
perhaps had the biggest impact on the protein S-acylation field, where prediction of 
substrate proteins has been more difficult than in the N-myristoylation and isoprenylation 
fields, primarily due to the lack of a reFRJQLVHG ³FRQVHQVXV´ VHTXHQFH IRU protein S-
acylation. 
Several studies have implemented click chemistry protocols together with other new 
approaches such as acyl-biotin exchange and acyl-RAC (resin-assisted capture) to profile 
the S-acylated proteome from a variety of different cell types, revealing that perhaps as 
much as 10% of the proteome in mammalian cells is modified by S-acylation [11-13]. Indeed, 
a database of all known S-acylated proteins has now been developed [14] 
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(http://swisspalm.epfl.ch/), helping to establish user-friendly tools to support new 
investigators entering this research field. 
The technical breakthroughs that have benefitted the protein S-acylation field have been 
complemented by important new discoveries, in particular around the enzymes that catalyse 
this process. Identification of the enzymes that mediate protein S-acylation lagged a long 
way behind similar work in the N-myristoylation and isoprenylation fields. Moreover, 
enzymes that mediate protein deacylation (the reverse reaction) were identified long before 
the discovery of bona fide enzymes that catalyse S-acylation [15]. The big breakthrough in 
the search for protein acyltransferases (PATs) came through studies in Saccharomyces 
cerevisiae, which identified Erf2p and Akr1 as enzymes that catalyse the S-acylation of Ras 
and the casein kinase Yck2, respectively [16-18]. These two yeast PAT enzymes were found 
WRVKDUHDFRQVHUYHG³'++&´F\VWHLQH-rich domain (CRD), a 51 amino acid zinc finger-like 
domain displaying a high density of cysteine residues and with a conserved DHHC 
tetrapeptide (Akr1 actually has a DYHC sequence rather than the canonical DHHC 
sequence). These breakthrough discoveries served as the primer for later studies on 
mammalian cells that identified a family of twenty-four ZDHHC genes [6], and it is now 
generally accepted that zDHHC enzymes are responsible for the major bulk of S-acylation 
reactions that occur in cells [19]. However, the identification of the substrate pools of 
individual zDHHC enzymes has not been as successful and straightforward as may have 
originally been envisaged. 
 
A broad palette of proteins is regulated by S-acylation 
The range of proteins modified by S-acylation is diverse and includes both soluble and 
transmembrane proteins (single pass to polytopic). Soluble proteins often depend upon S-
acylation to become membrane associated. In some cases, this membrane association is 
relatively stable and proteins do not cycle between membrane-bound and cytosolic forms 
[20]. However, dynamic turnover of S-acylation is an essential means to regulate membrane-
cytosol exchange of proteins such as S-acylated Ras isoforms [21, 22] and is important in 
controlling the precise intracellular distribution of these proteins. Dynamic S-acylation cycles 
have also been reported to control membrane association of proteins such as G protein  
subunits [23] and the post-synaptic scaffold PSD95 [24]. In contrast, deacylation of the 
SNARE membrane fusion protein SNAP25 appears to occur at a slower rate than proteins 
such as Ras [25]. SNAP25 is S-acylated on up to four cysteines, and as a result of this 
multiple S-acylation and a slower rate of S-acylation turnover, SNAP25 is not thought to 
cycle between membranes and the cytosol. Instead, it was demonstrated that turnover of S-
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acylation (likely on specific cysteines) acts as a means to regulate the distribution of this 
protein between the plasma membrane and recycling endosomes [25]. 
As S-acylation is mediated by membrane-associated zDHHC enzymes, modified proteins 
require a mechanism to associate with membranes housing the respective PAT enzyme 
prior to S-acylation 7KH UROH RI ³GXDO DF\ODWLRQ´ LQ UHgulating membrane association of 
soluble proteins is well-established [26]. Essentially, the attachment of N-myristoyl or 
isoprenyl chains provides a weak membrane affinity that allows the proteins to transiently 
associate with membranes (and hence gain access to membrane-associated zDHHC 
enzymes). Subsequent S-acylation of cysteines adjacent to the N-myristoylation or 
isoprenylation site leads to a large increase in membrane affinity and promotes stable 
membrane attachment (at least of model peptides with model membranes) [26]. The precise 
membrane affinity of dual lipid anchors is likely to be influenced by other biochemical 
features of the protein but dual lipidated proteins clearly become enriched on cell 
membranes. As discussed above, the addition of an irreversible lipid anchor (N-
myristoylation or isoprenylation) and a reversible one (S-acylation) allows for dynamic 
regulation of membrane association via constitutive or regulated S-acylation turnover. It is 
not clear exactly how dynamic turnover of S-acylation on soluble proteins (or any protein) is 
regulated, however mechanisms regulating physical access of zDHHC enzymes to their 
substrates have been described [27] and there is also evidence for S-acylation enzymes 
being modulated by phosphorylation [28]. Similarly, phosphorylation of substrate proteins is 
also likely to play a role in regulating S-acylation dynamics [29, 30]. 
Although it is clear that S-acylation plays a major role in regulating membrane association of 
soluble proteins, it has been more challenging to tease apart other effects of S-acylation on 
these proteins. In contrast, there is an emerging wealth of information on the various effects 
that S-acylation has on transmembrane proteins. In particular, S-acylation appears to play 
an essential role in intracellular trafficking and protein stability [31, 32]. Mechanisms that 
have been proposed to underlie the effects of S-acylation on protein trafficking include: (i) 
regulating hydrophobic matching of transmembrane domains with the core of the lipid bilayer 
[33]; (ii) affecting the interaction of proteins with accessory trafficking factors [34]; and (iii) 
regulating interaction with membrane subdomains such as lipid rafts or caveolae [20, 35]. 
Protein stability can be affected by the localisation of S-acylated proteins and there is also 
good evidence that blocking S-acylation can enhance ubiquitination [36], highlighting an 
interesting interplay between post-translational modifications in the regulation of protein 
stability and turnover. 
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S-acylation enzymes 
The identification of enzymes that mediate protein deacylation preceded the discovery of S-
acylation enzymes by many years. Acyl protein thioesterase (APT) was identified as a 
cytosolic protein that was active against S-acylated substrates such as Ras proteins, G 
alpha subunits and eNOS but which lacked activity against caveolin-1 [15, 37]. These 
findings are consistent with the observation that caveolin-1 S-acylation is relatively stable 
[38] compared with the other proteins. In addition to APT, a separate deacylation enzyme, 
protein palmitoyl transferase (PPT), was also identified [39, 40]. In contrast to APT, PPT is 
localised to lysosomes [41], where it functions in degradation of S-acylated proteins. PPT 
has been of additional interest due to the finding that mutations that block the activity or 
lysosomal targeting of this enzyme cause infantile neuronal ceroid lipofuscinosis, a rare 
early-onset neurodegenerative disease [42]. Recent breakthroughs have highlighted that 
many more thioesterase enzymes are likely to be present in the wider metabolic serine 
hydrolase enzyme family, and that the total number of deacylation enzymes may be on a par 
with the number of known PATs [43, 44]. 
zDHHC enzymes have now been established as the PATs that regulate the large bulk of 
protein S-acylation reactions. These enzymes catalyse S-acylation via a two-step reaction 
involving attachment of the fatty acid onto the cysteine of the DHHC motif, a process known 
as autoacylation, followed by transfer of the acyl group onto the substrate protein [45, 46]. 
These polytopic membrane proteins are localised predominantly to endoplasmic reticulum 
and Golgi membranes [47, 48] but some isoforms display dynamic patterns of localisation: 
zDHHC2 localises to the plasma membrane and endosomes [49] and exhibits an enhanced 
targeting to the neuronal plasma membrane following blockade of action potential with 
tetrodotoxin [27]; zDHHC5 also exhibits a dynamic localisation, with neuronal activity 
enhancing endocytosis of this enzyme [50]. 
Several links have been established or suggested between zDHHC enzymes and different 
human disorders. A SNP in the ZDHHC8 gene has been linked to an increased susceptibility 
of developing schizophrenia [51], although this has not been a consistent finding across 
populations [52-54]. At the cellular level, knockout of zDHHC8 in mice leads to reduced 
dendritic complexity [55]. Mutations in zDHHC9 cause intellectual disability [56, 57] and 
specific disease-causing point mutations in the DHHC- cysteine-rich (CR) domain of this 
enzyme disrupt enzyme autoacylation [58], clearly linking defective palmitoylation to this 
disorder. zDHHC17 has been linked WRERWKGLDEHWHVDQG+XQWLQJWRQ¶VGLVHDVH]'++&
expression in pancreatic beta cells is reduced by inflammatory cytokines that cause beta cell 
dysfunction and apoptosis [59]. Indeed, RNAi-mediated depletion of zDHHC17 in a beta cell 
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line led to increased apoptosis and a reduction in glucose-stimulated insulin secretion [59]. 
7KH OLQNEHWZHHQ]'++&DQG+XQWLQJWRQ¶VGLVHDVH LVEDVHGRQHYLGHQFHVKRZLQJ WKDW
this enzyme S-acylates huntingtin, which prevents the formation of inclusions [60]. 
Furthermore, wild-type but not mutant huntingtin was shown to positively modulate 
zDHHC17 enzyme activity [61]. zDHHC13 is also able to S-acylate huntingtin [61] and 
zDHHC13-deficient mice also develop neuropathological and behaviour feature of 
HXQWLQJWRQ¶VGLVHDVH[62]; furthermore, mutations in this enzyme can result in hair loss and 
osteoporosis in mice [63, 64]. Finally, a number of zDHHC enzymes have been linked with 
cancer [65]. 
 
Protein substrate specificity of zDHHC enzymes 
Pinning down the substrates of individual zDHHC enzymes has been more difficult than 
many previously envisaged. There is an ever-increasing body of information about the 
zDHHC enzymes that can modify specific substrate proteins, informed mainly from zDHHC-
substrate co-expression experiments. However, possible overlap in the substrate profiles of 
individual zDHHC enzymes has limited the discovery of zDHHC substrate targets through 
knockout/knockdown strategies. For example, proteomic analysis of the S-acylated 
proteome in brain samples of zDHHC17 genetrap mice identified a number of potential 
substrates of this enzyme but the overall reduction in the level of S-acylation of these 
putative substrates was quite modest [66]. In this case, this may reflect the fact that the 
genetrap line used has a residual level of zDHHC17 expression (~ 10%) [67] and new 
models with a greater ablation of zDHHC17 may provide further insight into the substrates of 
this enzyme. An additional issue that has arisen with proteomics analyses is that changes 
detected in S-acylation of specific proteins sometimes actually reflect a decrease in overall 
protein abundance [68]. However given the known role of S-acylation in regulating protein 
stability [32], it is possible that proteins that exhibit changes in abundance are indeed 
substrates of the enzyme that has been depleted. This issue highlights the complexity of 
identifying zDHHC enzyme substrates, and careful follow-up analyses of proteomic datasets 
from zDHHC knockout models is essential to accurately define bona fide substrates of 
individual zDHHC enzymes. 
zDHHC enzymes can vary substantially in their affinities for their cognate substrate proteins 
and in their intrinsic S-acylation activities [69]. Hence, for S-acylation of a given substrate, 
zDHHCs with high S-acylation activity depend more on: i) the availability of this protein in 
proximity to this zDHHC (i.e. co-localisation in the same membrane compartment), and ii) 
the reactivity/ neighbouring context of the cysteines to be S-acylated, rather than on a strong 
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zDHHC-protein interaction; indeed the latter has been reported to be absent in the highly 
active zDHHC3 and zDHHC7 (Lemonidis et al 2014).  On the other hand, zDHHC enzymes 
with low S-acylation activity are likely to exhibit stronger interactions with their respective 
substrates, recognizing features of the proteins that may be located far away from the S-
acylated cysteines. zDHHC5 and zDHHC8 possess a long and highly disordered C-terminal 
tail, able to interact with structural aspects of many proteins (like PDZ domains), and such 
interactions quite frequently result in the S-acylation of the latter [70, 71]. zDHHC17 and 
zDHHC13, on the other hand,  contain an ankyrin-repeat domain, which enables them to 
bind to a number of known zDHHC17 substrates, including huntingtin, SNAP25 and 
cysteine-string protein (CSP) [69, 72]. We have recently shown that the ankyrin repeat 
domain of zDHHC17 and zDHHC13 can recognize disordered regions of these zDHHC17-
substrates; this is achieved by specific recognition of an evolutionary conserved sequence in 
these proteins that conforms to a [VIAP][VIT]xxQP consensus [73]. This finding is similar to 
some other ankyrin-repeat domains that can recognise linear unstructured sequences [74, 
75]. The importance of the zDHHC17 consensus binding site for S-acylation of the SNAP25 
family of proteins had been previously demonstrated in PC12 cells, as mutation of this site 
led to a large decrease in membrane binding [76]. Such sequences that can serve as 
zDHHC17/13-binding motifs are quite abundant, with at least 20 of them present only in 
known zDHHC17-binding proteins [73]. Although some of these sequences may not actually 
interact with the ankyrin repeat domain of zDHHC17/13, it is possible to predict accurately 
the sequences that do bind, by establishing a sequence rule-based consensus for ankyrin-
repeat binding based on peptide library screening [74]. 7KXV LW¶V SRVVLEOH WR SUHGLFW ZLWK
accuracy a number of zDHHC17/13 interactors, many of which could be novel substrates of 
these enzymes. Indeed, current efforts in our lab are focused on this direction. 
 
Lipid substrate specificity of zDHHC enzymes 
Palmitoyl-CoA appears to be the predominant lipid substrate used in cellular S-acylation 
reactions, however quantification of S-acyl chains attached to cellular proteins has also 
revealed significant amounts of stearate and oleate attached to S-acylated proteins [77]. In 
addition, other work has shown that a variety of exogenously supplied fatty acids can be 
incorporated into cellular S-acylated proteins, including polyunsaturated fatty acids [78]. 
These observations are important because the type of fatty acid added to S-acylated 
proteins could have a major effect on its intracellular localisation and function; for example, 
longer chain length fatty acids might be predicted to have a greater membrane affinity than 
shorter fatty acids. Moreover, it is generally accepted that saturated fatty acids can target 
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proteins to cholesterol-rich membrane sub-regions, whereas unsaturated fatty acids are 
thought to be excluded from these domains [20]. Elegant work from Jennings and Linder 
shed the first light on how zDHHC enzymes might contribute to heterogeneity in the lipid 
profile of S-acylated proteins [46], by showing different fatty acyl-CoA preferences of purified 
zDHHC2 and zDHHC3 when the enzymes were contained in detergent micelles. The key 
observation made in this study was that zDHHC2 was able to use both C16:0 and C18:0 
acyl CoAs equally well, whereas zDHHC3 exhibited a strong preference for C16:0 over 
C18:0 [46]. Recent work from our group has confirmed this observation in cells using 
clickable fatty acid and further shown that zDHHC enzymes more widely have marked 
differences in fatty acid selectivity [10]. For example, zDHHC17 and zDHHC23 exhibited a 
preference for C18:0 fatty acids over C16:0 and C14:0, whereas zDHHC3, zDHHC7 had 
selectivity for shorter chain fatty acids. 
zDHHC3 and zDHHC7 are closely-related enzymes that exhibit substantial overlap in their 
protein substrates [6]. Despite this, we observed that zDHHC7 used C18:0 as a substrate 
better than zDHHC3 did [10]. To identify the molecular basis for this difference, we 
undertook a detailed mutational analysis of zDHHC3 and found that transmembrane domain 
3 plays a key role in determining the fatty acid selectivity profile of this enzyme. Indeed, a 
single isoleucine residue in the middle of this transmembrane domain is critical in limiting the 
use of C18:0 fatty acid by zDHHC3. zDHHC7 contains a serine at the same position, and an 
isoleucine-to-serine switch in zDHHC3 improved the ability of this enzyme to use C18:0 fatty 
acid as a substrate [10]. Transmembrane domain 3 is located immediately downstream of 
the catalytic DHHC-CR domain and thus the isoleucine residue in this membrane-spanning 
region of zDHHC3 might act as a filter to determine the length of fatty acid substrate that can 
be added WRWKHHQ]\PHGXULQJµDXWRDF\ODWLRQ¶ 
In addition to providing new insight into mechanisms regulating fatty acid selectivity of 
zDHHC enzymes, this study also highlighted that azide fatty acids are very good mimics of 
endogenous fatty acids (as discussed above). Indeed, the fatty acid selectivity profiles that 
were observed for zDHHC3 and zDHHC7 using azide fatty acid probes were verified using 
tritiated versions of C16:0 and C18:0 [10]. 
 
Concluding Remarks 
Mechanisms controlling the substrate specificity of zDHHC enzymes are beginning to 
emerge. zDHHC17 and zDHHC13 are key enzymes required for neuronal function and also 
LPSOLFDWHG LQ +XQWLQJWRQ¶V GLVHDVH DQG other disorders. Our recent work shows that they 
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recognise via their ankyrin-repeat a conserved consensus sequence in multiple substrates 
and binding partners. This new information has not only provided a mechanism to predict 
new targets of these enzymes and to complement proteomic analyses, but is also expected 
to lead to a better understanding of the disease mechanisms associated with specific 
enzyme dysfunction. Hence, the identification of other consensus recognition sites for 
zDHHC enzymes is crucial. Our recent work has shown that clickable fatty acids are 
excellent tools to dissect the fatty acid selectivity of zDHHC enzymes and has provided a 
molecular basis on how this occurs for two zDHHC enzymes. It will be interesting to now 
investigate if similar selectivity mechanisms exist in other zDHHC enzymes, and how 
differences in selectivity impact endogenous protein substrates and cellular pathways. 
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